Medicis Global Service Corporation

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Medicis Global Service Corporation sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials none currently recruiting 10 completed later-stage tilt top decile by trial count

Medicis Global Service Corporation: 10 sponsored US clinical trials, none currently recruiting.

Medicis Global Service Corporation sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 10 completed. 6 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Nasolabial Folds, with 1 trials.

Top-decile sponsor footprint

Medicis Global Service Corporation ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

10 total, page 1 of 1

COMPLETED Phase 2

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

NCT01703793
COMPLETED Phase 3

Safety and Efficacy Study to Treat Bacterial Vaginosis

NCT01621399
COMPLETED Phase 3

Topical Antifungal Treatment for Tinea Pedis

NCT01396785
COMPLETED Phase 3

Topical Antifungal Treatment for Tinea Pedis

NCT01396811
COMPLETED Phase 3

Topical Antifungal Treatment for Tinea Cruris

NCT01342315
COMPLETED Phase 4

Combination Treatment for Moderate to Severe Acne

NCT01206348
COMPLETED Phase 4

Study of Restylane and Perlane in the Correction of Peri-Oral Wrinkles

NCT00977704
COMPLETED NA

Safety/Efficacy Study of Restylane® in Lip Augmentation

NCT00935272
COMPLETED NA

Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose

NCT00823069
COMPLETED NA

Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds

NCT00797459

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 4
Phase 4 2

Therapeutic Areas

Nasolabial Folds 1

How the Medicis Global Service Corporation archive is shaped

10 indexed studies, none listed as recruiting (0% open); 10 completed (100%).

Phase mix: 6 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Nasolabial Folds (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Medicis Global Service Corporation: archived-pipeline peers nationwide

Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Medicis Global Service Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Medicis Global Service CorporationAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron Pharmaceuticals10xBio22nd Century Group23andMe3-C Institute for Social Development
Medicis Global Service Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medicis Global Service Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Medicis Global Service Corporation page

10 registered trials is a research-attention snapshot, not an endorsement of Medicis Global Service Corporation or any single study.

  • None of Medicis Global Service Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Nasolabial Folds is the condition Medicis Global Service Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Nasolabial Folds trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Medicis Global Service Corporation pipeline card: 10 registered trials from official public datasets.Report a data error.